In lung adenocarcinoma, STK11/KEAP1 commutation leads to resistance to pharmacologically induced ferroptosis and high expression of ferroptosis-protective genes, which is associated with early death and aggressive tumor development (Wohlhieter et al., 2020). The gene discussed is STK11; the disease is neoplasm.